Precision medicine for continuing phenotype expansion of Human Genetic diseases

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Yu, Hui ^a   Zhang, Victor Wei ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; EPISTASIS; GENETIC DISORDER; GENETIC HETEROGENEITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; PERSONALIZED MEDICINE; PHENOTYPE; PRECISION MEDICINE; REVIEW; GENOMICS; HUMAN GENOME;

GENETIC DISEASES, INBORN; GENOME, HUMAN; GENOMICS; HUMANS; PHENOTYPE; PRECISION MEDICINE;

EID: 84934922127     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/745043     Document Type: Review

References (31)

1. Y. Yang, D. M. Muzny, J. G. Reid et al. , "Clinical whole-exome sequencing for the diagnosis of mendelian disorders, " The New England Journal ofMedicine, vol. 369, no. 16, pp. 1502-1511, 2013.
2. S. Tang, J. Wang, N.-C. Lee et al. , "Mitochondrial DNA polymerase mutations: an ever expanding molecular and clinical spectrum, " Journal of Medical Genetics, vol. 48, no. 10, pp. 669-681, 2011.
3. S. Parikh, A. Goldstein, M. K. Koenig et al. , "Practice patterns of mitochondrial disease physicians in North America. Part 1: diagnostic and clinical challenges, " Mitochondrion, vol. 14, no. 1, pp. 26-33, 2014.
4. T. J. Dixon-Salazar, J. L. Silhavy, N. Udpa et al. , "Exome sequencing can improve diagnosis and alter patient management, " Science TranslationalMedicine, vol. 4, no. 138, Article ID 138ra78, pp. 138-178, 2012.
5. M. C. Barboza-Cerda, L. D. Campos-Acevedo, R. Rangel, L. E. Martńez-de-Villarreal, and M. A. Déctor, "A novel phenotype characterized by digital abnormalities, intellectual disability, and short stature in a Mexican family maps to Xp11. 4-p11. 21, " American Journal of Medical Genetics Part A, vol. 161, no. 2, pp. 237-243, 2013.
6. M. C. Barboza-Cerda, L.-J. Wong, L. E. Martńez-de-Villarreal, V. W. Zhang, and M. A. Déctor, "A novel EBP c. 224T>A mutation supports the existence of a male-specific disorder independent of CDPX2, " The American Journal of Medical Genetics Part A, vol. 164, no. 7, pp. 1642-1647, 2014.
7. J. C. Marini, A. Forlino, W. A. Cabral et al. , "Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans, " Human Mutation, vol. 28, no. 3, pp. 209-221, 2007.
8. J. Rainger, D. Pehlivan, S. Johansson et al. , "Monoallelic and biallelic mutations in MAB21L2 cause a spectrum of major eye malformations, "The American Journal of Human Genetics, vol. 94, no. 6, pp. 915-923, 2014.
9. J. de Ligt, P. M. Boone, R. Pfundt et al. , "Detection of clinically relevant copy number variants with whole-exome sequencing, " Human Mutation, vol. 34, no. 10, pp. 1439-1448, 2013.
10. C. S. Poultney, A. P. Goldberg, E. Drapeau et al. , "Identification of small exonic CNV from whole-exome sequence data and application to autism spectrum disorder, " American Journal of Human Genetics, vol. 93, no. 4, pp. 607-619, 2013.
11. A. Moreno-De-Luca, S. M. Myers, T. D. Challman, D. Moreno-De-Luca, D. W. Evans, and D. H. Ledbetter, "Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence, " The Lancet Neurology, vol. 12, no. 4, pp. 406-414, 2013.
12. N. Wu, X. Ming, J. Xiao et al. , "TBX6 null variants and a common hypomorphic allele in congenital scoliosis, " The New England Journal of Medicine, vol. 372, no. 4, pp. 341-350, 2015.
13. L. N. Moens, E. Falk-Sörqvist, A. C. Asplund et al. , "Diagnostics of primary immunodeficiency diseases: a sequencing capture approach, " PLoS ONE, vol. 9, no. 12, Article IDe114901, 2014.
14. A. C. Need, V. Shashi, Y. Hitomi et al. , "Clinical application of exome sequencing in undiagnosed genetic conditions, " Journal of Medical Genetics, vol. 49, no. 6, pp. 353-361, 2012.
15. A. M. Waters and P. L. Beales, "Ciliopathies: an expanding disease spectrum, " Pediatric Nephrology, vol. 26, no. 7, pp. 1039-1056, 2011.
16. J. L. Badano, C. C. Leitch, S. J. Ansley et al. , "Dissection of epistasis in oligogenic Bardet-Biedl syndrome, " Nature, vol. 439, no. 7074, pp. 326-330, 2006.
17. J. L. Bandano, J. C. Kim, B. E. Hoskins et al. , "Heterozygous mutations in BBS1, BBS2 and BBS6 have a potential epistatic effect on Bardet-Beidl patients with two mutations at a second BBS locus, " Human Molecular Genetics, vol. 12, no. 14, pp. 1651-1659, 2003.
18. V. Marion, F. Stutzmann, M. Gérard et al. , "Exome sequencing identifies mutations in LZTFL1, a BBSome and smoothened trafficking regulator, in a family with Bardet-Biedl syndrome with situs inversus and insertional polydactyly, " Journal of Medical Genetics, vol. 49, no. 5, pp. 317-321, 2012.
19. A. M. Rose, A. Z. Shah, G. Venturini, C. Rivolta, G. E. Rose, and S. S. Bhattacharya, "Dominant PRPF31mutations are hypostatic to a recessive CNOT3 polymorphism in retinitis pigmentosa: a novel phenomenon of 'linked trans-acting epistasis', " Annals of Human Genetics, vol. 78, no. 1, pp. 62-71, 2014.
20. B. Weigelt and J. S. Reis-Filho, "Epistatic interactions and drug response, " Journal of Pathology, vol. 232, no. 2, pp. 255-263, 2014.
21. B. R. Korf and H. L. Rehm, "New approaches to molecular diagnosis, "The Journal of the AmericanMedical Association, vol. 309, no. 14, pp. 1511-1521, 2013.
22. D. T. Miller, M. P. Adam, S. Aradhya et al. , "Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies, " American Journal of Human Genetics, vol. 86, no. 5, pp. 749-764, 2010.
23. D. C. Koboldt, K. M. Steinberg, D. E. Larson, R. K. Wilson, and E. R. Mardis, "The next-generation sequencing revolution and its impact on genomics, " Cell, vol. 155, no. 1, pp. 27-38, 2013.
24. C. L. Beaulieu, J. Majewski, J. Schwartzentruber et al. , "FORGE Canada Consortium: outcomes of a 2-year national rare-disease gene-discovery project, "The American Journal ofHumanGenetics, vol. 94, no. 6, pp. 809-817, 2014.
25. T. A. Manolio, R. L. Chisholm, B. Ozenberger et al. , "Implementing genomic medicine in the clinic: the future is here, " Genetics in Medicine, vol. 15, no. 4, pp. 258-267, 2013.
26. S. Köhler, S. C. Doelken, C. J. Mungall et al. , "The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data, " Nucleic Acids Research, vol. 42, no. 1, pp. D966-D974, 2014.
27. N. Wagle, M. F. Berger, M. J. Davis et al. , "High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing, " Cancer Discovery, vol. 2, no. 1, pp. 82-93, 2012.
28. A. R. Hansen and P. L. Bedard, "Clinical application of highthroughput genomic technologies for treatment selection in breast cancer, " Breast Cancer Research, vol. 15, no. 5, article R97, 2013.
29. J. G. Bender, A. Verma, and J. D. Schiffman, "Translating genomic discoveries to the clinic in pediatric oncology, " Current Opinion in Pediatrics, vol. 27, no. 1, pp. 34-43, 2015.
30. M. Kalia, "Biomarkers for personalized oncology: recent advances and future challenges, " Metabolism, vol. 64, no. 3, supplement 1, pp. S16-S21, 2015.
31. A.-L. Barabási, N. Gulbahce, and J. Loscalzo, "Network medicine: a network-based approach to human disease, " Nature Reviews Genetics, vol. 12, no. 1, pp. 56-68, 2011.